In vitro activity of imipenem/relebactam, meropenem/vaborbactam, ceftazidime/avibactam, cefepime/zidebactam and other novel antibiotics against imipenem-non-susceptible Gram-negative bacilli from Taiwan.
Shu-Chen KuoYung-Chih WangMei-Chen TanWei-Cheng HuangYih-Ru ShiauHui-Ying WangJui-Fen LaiI-Wen HuangTsai-Ling LauderdalePublished in: The Journal of antimicrobial chemotherapy (2021)
β-Lactam/BLI-BLE combinations were active in a higher proportion of INS-EC, INS-KP and INS-PA. The susceptibility of novel fluoroquinolones and tetracyclines was not superior to that of old ones.
Keyphrases